ERBB2 and breast cancer: Consistently, we found conditional Srsf3 KO in mouse mammary glands prevent c-neu (Erbb2) expression and thus, Erbb2 breast cancer induction, providing for the first time the direct in vivo evidence of Srsf3’s oncogenic feature.